• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: chiauranib
Date Designated: 09/02/2021
Orphan Designation: Treatment of small cell lung cancer
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Shenzhen Chipscreen Biosciences Co., Ltd.
2-601, BIO-Incubator, Gaoxin C, 1st Ave.,
Hi-Tech Industrial Park, Nanshan District
Shenzhen, Guangdong 518057

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.